Based on 4 Analyst Ratings
258.68% Upside
Date | Brokerage Firm | Analyst Name | Price Target | Price when Posted | Upside/Downside on Report Date | Details |
---|---|---|---|---|---|---|
05/13/2024 | Stephens | Sudan Loganathan | $25.00 | $8.86 | 182.17% |
A. Actinium Pharmaceuticals, Inc. has been rated by research analysts at Stephens in the past 90 days.